A New Fron­tier: The In­ner Ear

Yesterday

2019 Trin­i­ty Drug In­dex Eval­u­ates Ac­tu­al Com­mer­cial Per­for­mance of Nov­el Drugs Ap­proved in 2016

Last week

How to cap­i­talise on a lean launch

Last week

Turn­ing the cor­ner on treat­ing the root cause of sick­le cell dis­ease

2 weeks ago

Es­sen­tial cri­te­ria bio­phar­ma­ceu­ti­cal in­vestors seek when eval­u­at­ing com­pounds and com­pa­nies

3 weeks ago

In­vent­ing Med­i­cine by Ac­cess­ing the Hid­den Trea­sure in the Hu­man Mi­cro­bio­me’s Dark Mat­ter

4 weeks ago

De­vel­op­ment of the Next Gen­er­a­tion NKG2D CAR T-cell Man­u­fac­tur­ing Process

Last month

Part­ner with the right bio­an­a­lyt­ics firm at start-up to de-risk drug de­vel­op­ment

2 months ago

Con­quer­ing a silent killer: HDV and Eiger Bio­Phar­ma­ceu­ti­cals

2 months ago

Com­mu­ni­cat­ing the val­ue of pre­ci­sion med­i­cine

2 months ago

Prac­ti­cal im­pli­ca­tions of re­cent FDA guid­ance on im­muno­genic­i­ty risk as­sess­ments on your IND sub­mis­sions

3 months ago

RWE chal­lenges for to­day's bio­phar­ma

3 months ago

Med­ical an­i­ma­tion: Mak­ing it eas­i­er for the site and the pa­tient to un­der­stand

3 months ago

Novotech CRO sees 26% growth in Asia tri­al ac­tiv­i­ty from biotechs, but still plen­ty of ca­pac­i­ty

3 months ago

The next 10 years: Where is biotech head­ed?

3 months ago

Lead­ing the Next CAR T Rev­o­lu­tion in Can­cer

4 months ago

Solv­ing the chal­lenge of nu­cle­ic acid de­liv­ery in RNA med­i­cines

6 months ago

Novotech CRO Ex­pands Chi­na Team as Biotech De­mand for Clin­i­cal Tri­als In­creas­es up to 79%

6 months ago

Novotech CRO Award­ed Frost & Sul­li­van Best Biotech CRO Asia-Pa­cif­ic 2019

7 months ago

How small- to mid-sized biotechs can adopt pa­tient cen­tric­i­ty in their on­col­o­gy tri­als

7 months ago

De­liv­er­ing CNS-fo­cused pa­tient in­no­va­tions

8 months ago

Boost­ing check­point in­hibitor ef­fi­ca­cy via the mi­cro­bio­me

8 months ago

How the sur­gi­cal set­ting con­tributes to the opi­oid cri­sis

10 months ago

Fol­licum, a Swedish biotech com­pa­ny born to find a treat­ment for hair loss, now has di­a­betes in its crosshairs

11 months ago
12 Next page Last page